Amy Mahery

Amy Mahery has more than twenty years of experience in the biopharmaceutical industry. She has held diverse global and U.S. commercial leadership roles spanning sales, marketing, and market access where she has been involved in the commercialization and launch of drugs in varied therapeutic areas including oncology, neurology, and immunology. Amy previously held multiple leadership roles at EMD Serono, Inc (Merck KGaA). Most recently, she served as Senior Vice President and Head of Global Franchise, Neurology and Immunology (N&I) at EMD Serono where she developed and led the implementation of the end-to-end franchise strategy for the N&I portfolio. Prior to that, Amy led worldwide access strategy development across Oncology, Neurology, Immunology, Fertility, and General Medicines to create advanced approaches to pricing, reimbursement, and patient access as Senior Vice President and Head of Global Market Access and Pricing. Amy holds a holds a B.S. in Neuroscience from Trinity College.